# US 2026/0074041 A1 · Methods of treatment and interventions for improving or maintaining health and wellness based on quantitative assessment of biomarker levels > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 2026/0074041 A1 - Document ID: US20260074041A1 - Status: Published application - Kind: A1 - Application number: 19/326,027 - Filed: 2025-09-11 - Published: 2026-03-12 - Earliest claimed: 2024-09-12 - Assignees: Matter Neuroscience Inc. - Applicants: Matter Neuroscience Inc. - Inventors: Axel BOUCHON - Web page: https://patentgrep.com/patent/US20260074041A1 ## CPC - G16H 20/00: ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance - G16H 10/60: for patient-specific data, e.g. for electronic patient records - G16H 15/00: ICT specially adapted for medical reports, e.g. generation or transmission thereof - G16H 20/10: relating to drugs or medications, e.g. for ensuring correct administration to patients - G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems - G16H 50/30: for calculating health indices; for individual health risk assessment - G16H 50/70: for mining of medical data, e.g. analysing previous cases of other patients - G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA ## Abstract Provided are methods, systems including one or more processors, and computer-readable media storing instructions which, when executed by the system, cause the system to execute the method, the method including: obtaining biomarker data representing biomarker levels for different molecules for a patient; determining, based on the obtained data and using a knowledge graph linking intervention modules, target biomarker ranges, and outcomes, that at least one of the biomarker levels for the patient do not fall within the one or more target biomarker ranges; selecting, based on the obtained data and using the knowledge graph, one of the respective intervention modules associated with the biomarker level that does not fall within the target biomarker range; selecting an intervention associated with the selected intervention module; and generating, by an outputter, an output indicating the selected intervention. ## Claims ### Claim 1 A method to improve and maintain molecular biomarker levels in a patient, comprising: obtaining biomarker data representing a plurality of biomarker levels for a plurality of different molecules for a patient; determining, based on the obtained data representing the plurality of biomarker levels and using a knowledge graph linking one or more intervention modules, one or more target biomarker ranges, and one or more outcomes, that at least one of the plurality of biomarker levels for the patient do not fall within the one or more target biomarker ranges; selecting, based on the obtained data and using the knowledge graph, a first one of the plurality of respective intervention modules associated with the at least one biomarker level that does not fall within the target biomarker range; selecting a first intervention associated with the selected first intervention module; and generating, by an outputter, an output indicating the selected first intervention. ### Claim 2 (depends on 1) The method of claim 1, comprising: selecting, based on the selected intervention module, one or more continuous monitoring tools from a set of continuous monitoring tools; and obtaining updated biomarker data, via the one or more continuous monitoring tools, indicative of the changes in biomarker levels of the patient in response to the selected first intervention. ### Claim 3 (depends on 2) The method of claim 2, comprising: determining, after the changes in biomarker levels, that the changed biomarker levels of the patient fall within the one or more target ranges; and in response to the determination that the changed biomarker levels of the patient fall within the one or more target ranges, generating, by the outputter, a second output indicating a subsequent second intervention module and a selected second intervention therein. ### Claim 4 (depends on 2) The method of claim 2, comprising: determining, after the changes in biomarker levels, that the changed biomarker levels of the patient do not fall within the one or more target ranges; and in response to the determination that the changed biomarker levels of the patient do not fall within the one or more target ranges, generating, by the outputter, a third output indicating an escalated intervention within the first intervention module. ### Claim 5 (depends on 2) The method of claim 2, wherein the one or more continuous monitoring tools comprise one or more tools selected from: a survey and/or automated GUI-based data collection tool; a wearable device for monitoring blood glucose levels; a wearable device for monitoring cortisol levels; a wearable device for monitoring sleep quality, physical activity levels, stress levels, and/or emotional states correlating with high arousal states; and a wearable device for monitoring movement data, elevation data, and/or co-location or proximity data with other persons. ### Claim 6 (depends on 1) The method of claim 1, wherein the plurality of different molecules for the patient include one or more molecules selected from: Dopamine; Testosterone and/or Estrogen (which in some embodiments may be referred to and/or quantified as a testosterone level); Serotonin; Oxytocin; Arachidonoyl ethanolamine (AEA) and/or 2-archidonoyl glycerol (2-AG); beta-Endorphin; Cortisol; Adrenaline and/or Noradrenalin; Brain-derived neurotrophic factor (BDNF); and Eicosatetraenoic acid (EPA) and/or Docosahexaenoic acid (DHA). ### Claim 7 (depends on 1) The method of claim 1, wherein the plurality of different molecules for the patient include at least one of: one or more molecules involved in mitochondrial energy metabolism; one or more molecules involved in neuronal activation, enhanced cognition, and memory formation; one or more molecules involved in regulating acute and chronic inflammations; and one or more molecules involved in tumor suppression or activation. ### Claim 8 (depends on 1) The method of claim 1, wherein the plurality of different molecules for the patient include one or more molecules identified using at least one of: one or more metabolomic biomarker panels, fMRI and/or PET-tracer enhanced imaging techniques, epigenetics, one or more blood biomarker panels, one or more of transcriptomics, proteomics, microbiomics, and genomics test (OMICs), and one or more early cancer biomarker panels. ### Claim 9 (depends on 1) The method of claim 1, wherein selecting the first intervention module and selecting a first intervention therein is performed based on an AI inference model. ### Claim 10 (depends on 1) The method of claim 1, comprising administering the selected first intervention as a treatment to the patient. ### Claim 11 (depends on 10) The method of claim 10, comprising, following administering the selected first intervention, updating the knowledge graph based on a feedback loop that applies data corresponding to one or more updated biomarker levels for the patient to adjust the knowledge graph by making an adjustment selected from: adding or removing a node, adding or removing a link, adjusting a link type, adjusting a weighting of a link. ### Claim 12 (depends on 1) The method of claim 1, wherein the knowledge graph comprises a plurality of links, each link connecting a set of nodes of a plurality of nodes in the knowledge graph, and wherein each of the plurality of links are weighted with one of a plurality of different link weights. ### Claim 13 (depends on 1) The method of claim 1, wherein the knowledge graph comprises a plurality of links, each link connecting a set of nodes of a plurality of nodes in the knowledge graph, and wherein the plurality of links comprises a plurality of different types of links that are traversed differently from one another in determining that at least one of the plurality of biomarker levels for the patient do not fall within the one or more target biomarker ranges and selecting the first intervention module using the knowledge graph. ### Claim 14 A system comprising one or more processors and memory storing instructions configured to be executed by the one or more processors to cause the system to: obtain data representing a plurality of biomarker levels for a plurality of different molecules for a patient; determine, based on the obtained data representing the plurality of biomarker levels and using a knowledge graph linking one or more intervention modules, one or more target biomarker ranges, and one or more outcomes, whether at least one of the plurality of biomarker levels for the patient fall within the one or more target biomarker ranges; based on a determination that the at least one of the plurality of biomarker levels do not fall within the one or more target biomarker ranges, select, based on the obtained data and using the knowledge graph, a first one of the plurality of respective intervention modules associated with the at least one biomarker level that does not fall within the target biomarker range; select a first intervention associated with the selected first intervention module; and generate, by an outputter, an output indicating the selected first intervention. ### Claim 15 (depends on 14) The system of claim 14, wherein the instructions configured to be executed by the one or more processors cause the system to: select, based on the selected intervention module, one or more continuous monitoring tools from a set of continuous monitoring tools; and obtain updated biomarker data, via the one or more continuous monitoring tools, indicative of the changes in biomarker levels of the patient in response to the selected first intervention. ### Claim 16 (depends on 15) The system of claim 15, wherein the instructions configured to be executed by the one or more processors cause the system to: determine, after the changes in biomarker levels, whether the changed biomarker levels of the patient fall within the one or more target ranges; in response to a determination that the changed biomarker levels of the patient fall within the one or more target ranges, generate, by the outputter, a second output indicating a subsequent second intervention module and a selected second intervention therein. ### Claim 17 (depends on 16) The system of claim 16, wherein the instructions configured to be executed by the one or more processors cause the system to, in response to a determination that the changed biomarker levels of the patient do not fall within the one or more target ranges, generate, by the outputter, a third output indicating an escalated intervention within the first intervention module. ### Claim 18 (depends on 15) The system of claim 15, wherein the one or more continuous monitoring tools comprise one or more tools selected from: a survey and/or automated GUI-based data collection tool; a wearable device for monitoring blood glucose levels; a wearable device for monitoring cortisol levels; a wearable device for monitoring sleep quality, physical activity levels, stress levels, and/or emotional states correlating with high arousal states; and a wearable device for monitoring movement data, elevation data, and/or co-location or proximity data with other persons. ### Claim 19 (depends on 14) The system of claim 14, wherein the plurality of different molecules for the patient include one or more molecules selected from: Dopamine; Testosterone and/or Estrogen (which in some embodiments may be referred to and/or quantified as a testosterone level); Serotonin; Oxytocin; Arachidonoyl ethanolamine (AEA) and/or 2-archidonoyl glycerol (2-AG); beta-Endorphin; Cortisol; Adrenaline and/or Noradrenalin; Brain-derived neurotrophic factor (BDNF); and Eicosatetraenoic acid (EPA) and/or Docosahexaenoic acid (DHA). ### Claim 20 (depends on 14) The system of claim 14, wherein the plurality of different molecules for the patient include at least one of: one or more molecules involved in mitochondrial energy metabolism; one or more molecules involved in neuronal activation, enhanced cognition, and memory formation; one or more molecules involved in regulating acute and chronic inflammations; and one or more molecules involved in tumor suppression or activation. ### Claim 21 (depends on 14) The system of claim 14, wherein the plurality of different molecules for the patient include one or more molecules identified using at least one of: one or more metabolomic biomarker panels, fMRI and/or PET-tracer enhanced imaging techniques, epigenetics, one or more blood biomarker panels, one or more of transcriptomics, proteomics, microbiomics, and genomics test (OMICs), and one or more early cancer biomarker panels. ### Claim 22 (depends on 14) The system of claim 14, wherein selecting the first intervention module and selecting a first intervention therein is performed based on an AI inference model. ### Claim 23 (depends on 14) The system of claim 14, wherein the instructions configured to be executed by the one or more processors cause the system to update the knowledge graph based on a feedback loop that applies data corresponding to one or more updated biomarker levels for the patient to adjust the knowledge graph following the first invention by making an adjustment selected from: adding or removing a node, adding or removing a link, adjusting a link type, adjusting a weighting of a link. ### Claim 24 (depends on 14) The system of claim 14, wherein the knowledge graph comprises a plurality of links, each link connecting a set of nodes of a plurality of nodes in the knowledge graph, and wherein each of the plurality of links are weighted with one of a plurality of different link weights. ### Claim 25 (depends on 14) The system of claim 14, wherein the knowledge graph comprises a plurality of links, each link connecting a set of nodes of a plurality of nodes in the knowledge graph, and wherein the plurality of links comprises a plurality of different types of links that are traversed differently from one another in determining that at least one of the plurality of biomarker levels for the patient do not fall within the one or more target biomarker ranges and selecting the first intervention module using the knowledge graph. ### Claim 26 A non-transitory computer-readable storage medium storing instructions which, when executed by a system comprising one or more processors, cause the system to: obtain data representing a plurality of biomarker levels for a plurality of different molecules for a patient; determine, based on the obtained data representing the plurality of biomarker levels and using a knowledge graph linking one or more intervention modules, one or more target biomarker ranges, and one or more outcomes, whether at least one of the biomarker levels for the patient do not fall within the one or more target biomarker ranges; based on a determination that the at least one of the plurality of biomarker levels do not fall within the one or more target biomarker ranges, select, based on the obtained data and using the knowledge graph, a first one of the plurality of respective intervention modules associated with the at least one biomarker level that does not fall within the target biomarker range; select a first intervention associated with the selected first intervention module; and generate, by an outputter, an output indicating the selected first intervention.